Please login to the form below

Not currently logged in
Email:
Password:

Gilead sues Teva over patent for HIV drug

Biopharmaceutical company Gilead Sciences has filed a lawsuit in the US against Teva for infringement of its patents for Truvada

Biopharmaceutical company Gilead Sciences has filed a lawsuit in the US against Teva for infringement of its patents for Truvada, an antiretroviral agent for the treatment of HIV-1 in adults.

Teva has submitted an Abbreviated New Drug Application (ANDA) to the US Food and Drug Administration (FDA) requesting approval to manufacture and market a generic version of Truvada. Gilead has filed a lawsuit against the Israeli company as it claims it has two valid patents covering emtricitabine, a component of Truvada.

By filing a lawsuit, Gilead has temporarily put a stop to Teva's ANDA. The FDA is unable to approve the request for 30 months or until a court rules in favour of Teva.

Ten patents, all of which would need to be expired or invalidated before a generic version of the drug could be marketed, currently protect Truvada.

In November, PMLiVE reported that Cephalon and Eurand had filed a similar lawsuit against generic manufacturers Mylan and Barr relating to the muscle relaxant, Amrix.

As generic competition increases, we expect to see more manufacturers turning to the courts in a bid to defend their intellectual property.
 

15th December 2008

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Skills in Healthcare

At Skills in Healthcare, we are able to provide our customers with a professional set of sales capabilities. With our...

Latest intelligence

Erik Nordkamp
In conversation with Pfizer’s Erik Nordkamp
Pfizer’s UK general manager talks to PME about the NHS at 70, the potential of pharma partnerships and some lessons from Europe...
fig 1
Pharma social media
Posting frequency is down as companies take a ‘less is more’ approach...
Phillip Lee
The case for a second Brexit referendum: “We need the informed consent of the people”
Dr Phillip Lee MP is fighting to keep the UK in the EMA network - and for a second referendum...

Infographics